Atlas Trials

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT06609005 · RECRUITING

Trial details

NCT number
NCT06609005
Sponsor
Shenzhen Ionova Life Sciences Co., Ltd.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Metastatic Castration Resistant Prostate Cancer
Start date
2025-01-23
Primary completion
2028-01-17
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.